Section 2 - Clinical Risk Assessment and Care
Published online by Cambridge University Press: 15 May 2021
- Type
- Chapter
- Information
- Suicide PreventionStahl's Handbooks, pp. 73 - 186Publisher: Cambridge University PressPrint publication year: 2021
References
Primary Sources
Li, G., Fife, D., Wang, G., et al. (2019) All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population. Annals of General Psychiatry, 18: 23. doi: 10.1186/s12991-019-0248-0Google Scholar
Kellner, C. H., Fink, M., Knapp, R., et al. (2005) Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry, 162(5): 977–82. doi: 10.1176/appi.ajp.162.5.977Google Scholar
George, M. S., Raman, R., Benedek, D. M., et al. (2014) A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients. Brain Stimul, 7(3): 421–31.Google Scholar
Stahl, S. M. (2017) Stahl’s Essential Psychopharmacology Prescriber’s Guide, 6th Edn. Cambridge, UK: Cambridge University Press.Google Scholar
Secondary Sources
Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A., & Greil, W. (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders: data from a randomized prospective trial. Pharmacopsychiatry, 29: 103–7.Google Scholar
Müller-Oerlinghausen, B., Muser-Causemann, B., & Volk, J. (1992) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord, 25: 261–69.Google Scholar
Goodwin, F. K., Fireman, B., Simon, G. E., Hunkeler, E. M., Lee, J., & Revicki, D. (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA, 290: 1467–73.Google Scholar
Baldessarini, R. J., Tondo, L., Faedda, G. L., Suppes, T. R., Floris, G., & Rudas, N. (1996) Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry, 57: 441–48.Google Scholar
Cipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005) Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry, 162: 1805–19.Google Scholar
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord, 8: 625–39.Google Scholar
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. BMJ, 346: f3646.Google Scholar
Lewitzka, U., Severus, E., Bauer, R., Ritter, P., Müller-Oerlinghausen, B., & Bauer, M. (2015) The suicide prevention effect of lithium: more than 20 years of evidence–a narrative review. International Journal of Bipolar Disorders, 3(1): 32. doi: 10.1186/s40345-015-0032-2CrossRefGoogle ScholarPubMed
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord, 8(5 Pt 2): 625–39.Google Scholar
Guzzetta, F., Tondo, L., Centorrino, F., & Baldessarini, R. J. (2007) Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry, 68(3): 380–83.Google Scholar
Isometsä, E. (2014) Suicidal behaviour in mood disorders: Who, when, and why? Canadian Journal of Psychiatry. Revue canadienne de psychiatrie, 59(3): 120–30. doi.org/10.1177/070674371405900303Google Scholar
Lam, R. W., Kennedy, S. H., Grigoriadis, S., et al. (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III: pharmacopsychiatry. J Affect Disord, 117: 26–43. doi: 10.1016/j.jad.2009.06.041CrossRefGoogle Scholar
Pompili, M., Amador, X. F., Girardi, P., et al. (2007) Suicide risk in schizophrenia: learning from the past to change the future. Annals of General Psychiatry, 6: 10. doi: 10.1186/1744-859X-6-10Google Scholar
Meltzer, H. Y., & Okayli, G. (1995) Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 152(2): 183–90.Google ScholarPubMed
Correll, C. U., & Kane, J. M. (2019) Ranking antipsychotics for efficacy and safety in schizophrenia. JAMA Psychiatry. Published online November 06, 2019, doi.org/10.1001/jamapsychiatry.2019.3377Google Scholar
Leung, J. G., Cusimano, J., Gannon, J. M., et al. (2019) Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey. Int Clin Psychopharmacol, 34: 247–56.Google Scholar
Gee, S., Vergunst, F., Howes, O., & Taylor, D. (2014) Practitioner attitudes to clozapine initiation. Acta Psychiatr Scand, 130: 16–24.Google Scholar
Cohen, D. (2014) Prescribers fear as a major side-effect of clozapine. Acta Psychiatr Scand, 130: 154–55.Google Scholar
Carruthers, J., Radigan, M., Erlich, M. D., et al. (2016) An initiative to improve clozapine prescribing in New York State. Psychiatr Serv, 67: 369–71.CrossRefGoogle ScholarPubMed
Meyer, J. M., & Stahl, S. M. (2019) The Clozapine Handbook. New York, NY; Cambridge University Press.Google Scholar
Stahl, S. (2013) Mechanism of action of ketamine. CNS Spectrums, 18(4): 171–74. doi: 10.1017/S109285291300045XGoogle Scholar
Zarate, C. A., Singh, J. B., Carlson, P. J., et al. (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 63(8): 856–64.Google Scholar
Ionescu, D. F., Luckenbaugh, D. A., Niciu, M. J., Richards, E. M., & Zarate, C. A. Jr (2015) A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disorders, 17(4): 438–43. doi: 10.1111/bdi.12277Google Scholar
Murrough, J. W., Iosifescu, D. V., Chang, L. C., et al. (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry, 170(10): 1134–42. doi: 10.1176/appi.ajp.2013.13030392Google Scholar
Ballard, E. D., Yarrington, J. S., Farmer, C. A., et al. (2018) Characterizing the course of suicidal ideation response to ketamine. J Affect Disord, 241: 86–93. doi: 10.1016/j.jad.2018.07.077. Epub 2018 Jul 30.Google Scholar
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., et al. (2014) Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety. J Psychiatr Res, 58: 161–66. doi: 10.1016/j.jpsychires.2014.07.027. Epub Aug 12, 2014.Google Scholar
Wilkinson, S. T., Toprak, M., Turner, M. S., Levine, S. P., Katz, R. B., & Sanacora, G. (2017) A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders. Am J Psychiatry, 174(7): 695–96. doi: 10.1176/appi.ajp.2017.17020239Google Scholar
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., & Schatzberg, A. F., (2017) A consensus statement on the use of ketamine in the treatment of mood disorders. American Psychiatric Association Council of Research Task Force on Novel Biomarkers and Treatments. JAMA Psychiatry, 74(4): 399–405. doi: 10.1001/jamapsychiatry.2017.0080Google Scholar
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. (2019) Ketamine: A paradigm shift for depression research and treatment. Neuroview, 101(5): 774–78.Google Scholar
Daly, E. J., Trivedi, M. H., Janik, A., et al. (2019) Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry, 76(9): 893–903. Advance online publication. doi: 10.1001/jamapsychiatry.2019.1189Google Scholar
Cipriani, A., Furukawa, T. A., Salanti, G., et al. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet, 391(10128): 1357–66.Google Scholar
Davey, C. G., & Chanen, A. M. (2016) The unfulfilled promise of the antidepressant medications. Med J, 204: 348–50.Google Scholar
Wang, S. M., Han, C., Lee, S. J., et al. (2018) Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Rev Clin Pharmacol, 11: 15–25.Google Scholar
Ionescu, D. F., & Papakostas, G. L. (2017) Experimental medication treatment approaches for depression. Transl Psychiatry, 7: e1068.Google Scholar
Dragioti, E., Solmi, M., Favaro, A., et al. (2019) Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry. Published online October 02, 2019. doi: 10.1001/jamapsychiatry.2019.2859Google Scholar
Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2006) The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry, 163(11): 1898–904.Google Scholar
Baldessarini, R. J., & Tondo, L. (2007). Psychopharmacology of suicide prevention. In Tatarelli, R., Pompili, M. & Girardi, P. (Eds.), Suicide in Psychiatric Disorder New York: Nova Science Publications, 193–213.Google Scholar
Isacsson, G. (2000) Suicide prevention: A medical breakthrough? Acta Psychiatrica Scandinavica, 102: 113–17. doi: 10.1034/j.1600-0447.2000.102002113.xGoogle Scholar
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) Suicide risk during antidepressant treatment. Am J Psychiatry, 163(1): 41–7.Google Scholar
Hamilton, B. E., Miniño, A. M., Martin, J. A., Kochanek, K. D., Strobino, D. M., & Guyer, B. (2007) Annual summary of vital statistics: 2005. Pediatrics, 119 (2): 345–60. doi: 10.1542/peds.2006-3226CrossRefGoogle ScholarPubMed
Brent, D. A. (2016) Antidepressants and suicidality. Psychiatric Clinics, 39(3): 503–12.Google Scholar
Stahl, S. M. (2018) Prescriber’s Guide – Children and Adolescents: Stahl’s Essential Psychopharmacology. Cambridge, UK: Cambridge University Press.Google Scholar
Isacsson, G., & Rich, C. L. (2005) Antidepressant drug use and suicide prevention. International Review of Psychiatry, 17(3): 153–62. doi: 10.1080/09540260500071608Google Scholar
Olin, B., Jayewardene, A. K., Bunker, M., & Moreno, F. (2012) Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention. PLoS one, 7(10): e48002. doi: 10.1371/journal.pone.0048002CrossRefGoogle ScholarPubMed
Food and Drug Administration. (2016) Revisions to product labeling. Retrieved from www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM173233.pdf.Google Scholar
Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2016) The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry, 163(11): 1898–904.Google Scholar
Ludwig, J., Marcotte, D. E., & Norberg, K. (2009) Anti-depressants and suicide. J Health Econ, 28(3): 659–76.Google Scholar
Lu, C. Y., Zhang, F., Lakoma, M. D., Madden, J. M., Rusinak, D., Penfold, R. B., et al. (2014) Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: Quasi-experimental study. BMJ, 348: g3596. doi: 10.1136/bmj.g3596Google Scholar
Valuck, R. J., Libby, A. M., Sills, M. R., Giese, A. A., & Allen, R. R. (2004) Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder. CNS Drugs, 18: 1119–32. doi: 10.2165/00023210–200418150-00006CrossRefGoogle ScholarPubMed
Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., & Mann, J. J. (2007) Relationship between antidepressants and suicide attempts: An analysis of the Veterans Health Administration data sets. Am J Psychiatry, 164(7): 1044–49. doi: 10.1176/ajp.2007.164.7.1044Google Scholar
Bergen, H., Hawton, K., Murphy, E., et al. (2009) Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds. Br J Clin Pharmacol, 68(4): 618–29. doi: 10.1111/j.1365-2125.2009.03481.xGoogle Scholar
Hammad, T. A. (2004) Review and evaluation of clinical data [Internet]. Silver Spring: US Food and Drug Administration. Available from: www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf.Google Scholar
Friedman, R. A. (2014) Antidepressants’ black-box warning: 10 years later. N Engl J Med, 371: 1666–68.Google Scholar
Valuck, R. J., Libby, A. M., Orton, H. D., Morrato, E. H., Allen, R., & Baldessarini, R. J. (2007) Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry, 164: 1198–205.Google Scholar